10/12/2023MediLink, BioNTech Ink Strategic Collaboration and Worldwide License ...

10/12/2023NMPA and NHC Issues No.1 Supplement of ChP (2020)

10/12/2023Review of Chinese Biopharma Industry Performance in September 2023

10/12/2023China Approves Trial Use of Eisai/Biogen's Alzheimer Drug in Hainan's ...

10/12/2023China's Vast Opportunities In Health Care Attract Global Telemedicine ...

10/10/2023China Market Opportunities for International Pharmas (Lek)

10/10/2023NHSA Announces Conclusion of Expert Evaluation for 2023 DRDL Inclusion...

10/10/2023Sanofi, BioMap Partner to Develop Drug Discovery AI Modules

10/10/2023Bayer Pledges to Make More Investment in China

10/9/2023MNCs Wary of Pouring Big Investments in China While Actively Seeking L...

10/9/2023NHSA Solicits Comments on Draft of the Guiding Opinions on Strengtheni...

10/8/2023Recent Executive Movements

10/8/2023PharmaEssentia Enters Global License Deal with WuXi Bio for a Myeloid ...

10/7/2023CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...

10/4/2023PharmCube: Review of Chinese Hospital Drug Market MAT Q2/2023 (1)

10/4/2023Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023

10/3/2023CNIPA Invalides Novo's Core Chinese Patent for Semaglutide as Petition...

9/29/2023Recent Executive Moves

9/29/2023Financial-related Company News Digest (September 2023)

9/28/2023Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...

9/28/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...

9/28/2023CDE Solicits Comments on the Technical Guidelines for Clinical Efficac...

9/26/2023China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...

9/26/2023China Becomes Country with Highest and Increasingly Younger Alzheimer ...

9/26/2023SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...

9/26/2023WuXi Debuts First Vaccine CDMO Site in China

9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...

9/25/2023AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space

9/25/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...

9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...

Page:40/356 Total number of articles:10656: [First][<<] [38] [39] [40] [41] [42] [>>] [End]